Investigation of tumorigenicity frequency of CD133⁺ and CD133⁻ cells derived from four AT/RT patients in NOD/SCID xenotransplant assay.

Investigation of tumorigenicity frequency of CD133+ and CD133− cells derived from four AT/RT patients in NOD/SCID xenotransplant assay.本研究通过NOD/SCID异种移植检测（NOD/SCID xenotransplant assay），对4例非典型畸胎瘤样横纹肌样瘤（AT/RT，Atypical Teratoid Rhabdoid Tumor）患者来源的CD133阳性（CD133+）与CD133阴性（CD133−）细胞的致瘤频率进行了探究。